|Bid||23.93 x 0|
|Ask||23.94 x 0|
|Day's Range||23.84 - 24.10|
|52 Week Range||12.65 - 24.10|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||82.45|
|Forward Dividend & Yield||0.23 (0.96%)|
|Ex-Dividend Date||Nov 06, 2019|
|1y Target Est||N/A|
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
New CFO Deepak Ahuja is one of three new high-level hires at the South San Francisco-based subsidiary of Alphabet.
Examining ResMed Inc.'s (NYSE:RMD) past track record of performance is a useful exercise for investors. It allows us...
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of September 30. In this […]
Stocks traded near session highs as the S&P; 500 today climbed close to a record peak and Alphabet neared a buy point.
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of June 28. The results of that effort will be put on display in this article, as […]
With more than 10 million cloud-connected CPAP and other breathing devices on the market, CEO Mick Farrell completely understands why patients are wary about letting those devices send data to the cloud.
CEO of Resmed Inc (30-Year Financial, Insider Trades) Michael J. Farrell (insider trades) sold 6,651 shares of RMD on 09/09/2019 at an average price of $137.38 a share. Continue reading...
ResMed Inc (RMD) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. ResMed Inc is a part of the healthcare sector. Continue reading...
President and COO ResMed Inc. of Resmed Inc (30-Year Financial, Insider Trades) Robert Andrew Douglas (insider trades) sold 4,111 shares of RMD on 07/15/2019 at an average price of $124.5 a share. Continue reading...
CEO of Resmed Inc (NYSE:RMD) Michael J. Farrell sold 6,651 shares of RMD on 07/08/2019 at an average price of $123.76 a share.
Is ResMed Inc. (NYSE:RMD) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. […]
ResMed gapped up out of a downward-sloping flat base, surging on earnings. The maker of sleep apnea products reported better-than-expected earnings growth and the third straight quarter of slowly accelerating revenue growth.
Mick Farrell, ResMed CEO, joined Yahoo Finance from the New York Stock Exchange as the company celebrates its 20th year as a publicly traded company.